bioAffinity Technologies, Inc. (BIAF): Net earnings per share growth forecast for next year

bioAffinity Technologies (BIAF) - corporate logo

An assessment of the projected EPS dynamics for the coming year demonstrates the potential of bioAffinity Technologies (BIAF), where the current mark equals 0.00. Growth is driven by leadership in non-invasive oncology detection via AI-powered sputum analysis. Business stability is guaranteed by operating within the US jurisdiction without external pressure. Future financial success will rely on the mass adoption of the CyPath Lung diagnostic test.

BIAF: bioAffinity Technologies Inc. Net earnings per share growth forecast for next year 04/28/2023 - 11/11/2026

Metric breakdowns and analytics for bioAffinity Technologies, Inc. (BIAF)

- share price and consensus valuation forecast:
Stock Price bioAffinity Technologies Inc.|BIAF - Average Forecast Price
- stock exchange capitalization data:
Market Value bioAffinity Technologies|BIAF - Value Adjusted for Debt and Cash
- company book value details:
Book Value per Share bioAffinity Technologies|BIAF - Company Book Value|Market Capitalization to Book Value Ratio bioaffinitytech.com|BIAF - Company Total Asset Base
- company total debt and liquidity indicators:
Debt to Equity bioAffinity Technologies|BIAF - Long-Term Liabilities to Capital|Short-Term Debt to Capital bioAffinity Technologies Inc.|BIAF - Company Aggregate Debts|Debts to Book Capitalization bioAffinity Technologies|BIAF - Long-Term Liabilities|Company Short-Term Debts bioAffinity Technologies|Quick Ratio bioaffinitytech.com
- earnings and valuation multiples information:
BIAF - Net Financial Result|Expected Profit bioAffinity Technologies|BIAF - Price to Earnings Multiple|Forward P/E Multiple bioAffinity Technologies Inc.|BIAF - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio bioAffinity Technologies|BIAF - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months bioAffinity Technologies|BIAF - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months bioaffinitytech.com|BIAF - Earnings per share increase in current year|Expected earnings per share growth for next year bioAffinity Technologies
Basic company analysis:bioAffinity Technologies, BIAF
Core merchandise of bioAffinity Technologies, Inc.

To filter for high-quality assets, investors must distinguish market noise from the actual growth potential of net income. This metric measures the trend of expert earnings per share (EPS) expectations, which in the case of bioAffinity Technologies (BIAF) reflects the commercial success of integrating diagnostic systems into mandatory medical protocols, confirming steady demand for consumables via the projected EPS growth benchmark.

Who bioAffinity Technologies competes with

AVBP (ArriVent BioPharma, Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year Lantern LTRN|Net earnings per share growth forecast for next year eFFECTOR Therapeutics (EFTR)